
Classis Co., Ltd. (CEO Seunghan Baek ), a leading company in the global medical aesthetic medical device market, announced that it successfully held the 'Classis Global Customer Summit 2025', a global partner invitation event, at Vista Hall in the Grand Walkerhill Seoul Hotel in Gwangjin-gu, Seoul on the 23rd.
The event was the largest domestic and international partner invitation event held by Classis since its strategic merger with Iruda in 2024, and was attended by approximately 500 medical professionals from Korea and abroad, making it a great success. In particular, medical experts from major overseas markets such as the US, Japan, and Thailand participated in large numbers, confirming Classis' global status.
At the 'Classis Global Customer Summit 2025' event, Klassis prepared a time for overseas and domestic medical professionals to present clinical outcomes of Klassis products such as Shrink Universe, Volnumer, and Refit. Renowned medical professionals representing Singapore, Indonesia, Armenia, and Korea gave lectures, sharing their research findings, clinical results, and treatment know-how.
A total of four types of aesthetic medical devices were exhibited at the event, including Classys’ representative blockbuster HIFU device ‘Shrink Universe’, monopolar RF device ‘Volnumer’, next-generation laser device ‘Repot’ newly added after the merger with Iruda, and microneedling RF device scheduled for release in the second half of the year. In addition, photo zones and interview zones emphasizing the Classys brand were set up so that participants could immerse themselves and experience the Classys brand.
A Classys official said, “This Global Customer Summit is a meaningful event where we first showcased the synergy between the technologies and product portfolios of both companies since the merger with Iruda to our partners,” adding, “We will continue to communicate with our partners and develop innovative solutions to further solidify our leadership in the global medical aesthetics market.”
- See more related articles
You must be logged in to post a comment.